These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6133894)

  • 21. [Attempted immunological tumor therapy with sensitized allogeneic lymphoid cells in rats with benzopyrene sarcomas].
    Trepel F; Fink U; Ling G; Begemann H
    Z Immunitatsforsch Allerg Klin Immunol; 1969 Nov; 138(5):395-407. PubMed ID: 4244392
    [No Abstract]   [Full Text] [Related]  

  • 22. A new lymphocyte cell surface antigen, Ly-22.2, controlled by a locus on chromosome 4 and a second unlinked locus.
    Meruelo D; Offer M; Flieger N
    J Immunol; 1983 Feb; 130(2):946-50. PubMed ID: 6184409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of subcutaneous tumor with adoptively transferred T cells.
    Peng L; Shu S; Krauss JC
    Cell Immunol; 1997 May; 178(1):24-32. PubMed ID: 9184695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
    Matsumura T; Krinock RA; Chang AE; Shu S
    Cancer Res; 1993 Sep; 53(18):4315-21. PubMed ID: 8364926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response against large tumors eradicated by treatment with cyclophosphamide and IL-12.
    Tsung K; Meko JB; Tsung YL; Peplinski GR; Norton JA
    J Immunol; 1998 Feb; 160(3):1369-77. PubMed ID: 9570556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
    Evans R; Kamdar SJ; Duffy T; Edison L
    J Immunol; 1993 Jan; 150(1):177-84. PubMed ID: 8417123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of normal allogeneic lymphoid cell transfer in combination with chemotherapy on a transplantable tumor in rats.
    Yamada Y; Kawamura T; Gotohda E; Akiyama J; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1980 Mar; 40(3):954-8. PubMed ID: 6781744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modulation of cell surface structures. Characterization of differentiating thymus lymphocytes as well as "entdifferentiated" epithelial and lymphoblastic cells].
    Raedler A; Raedler E
    Bibl Anat; 1984; (25):1-80. PubMed ID: 6426457
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
    Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of the local antitumor action of inflammation.
    Alexander P; Parr IB; Jackson LE
    Transplant Proc; 1981 Dec; 13(4):1929-31. PubMed ID: 6977224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL.
    Schirrmacher V; Garrido F; Hübsch D; Garcia-Olivares E; Koszinowski U
    Transplant Proc; 1980 Mar; 12(1):32-7. PubMed ID: 6154357
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells.
    Greenberg PD; Cheever MA
    J Immunol; 1984 Dec; 133(6):3401-7. PubMed ID: 6149246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2.
    Merluzzi VJ; Welte K; Savage DM; Last-Barney K; Mertelsmann R
    J Immunol; 1983 Aug; 131(2):806-9. PubMed ID: 6134774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
    Takeuchi M; Kimoto M; Suzuki I; Nomoto K
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1980-6. PubMed ID: 6604499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of T lymphocyte subsets with monoclonal antibodies: discovery of a distinct marker, Ly-m22, of T suppressor cells.
    Chan MM; Tada N; Kimura S; Hoffmann MK; Miller RA; Stutman O; Hämmerling U
    J Immunol; 1983 May; 130(5):2075-8. PubMed ID: 6187835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
    Brunner KT; MacDonald HR; Cerottini JC
    J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in tumor-associated NK 1.1+ large granular lymphocyte precursors after cyclophosphamide injection: in vitro characterization and potential therapeutic application.
    Krupke DM; Fuller J; Aslakson C; Evans R
    Nat Immun; 1994; 13(5):246-57. PubMed ID: 7833624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Method of assessing the functional activity of tumor-associated suppressor cells].
    Iudin VM; Semenova-Kobzar' RA; Kushko LIa
    Eksp Onkol; 1984; 6(6):37-41. PubMed ID: 6241144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of immunotherapy on the kinetics of proliferation of a transplanted rat rhabdomyosarcoma.
    Gia DT; Loisillier F
    Eur J Cancer (1965); 1978 Oct; 14(10):1077-88. PubMed ID: 710477
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.
    Hermans IF; Chong TW; Palmowski MJ; Harris AL; Cerundolo V
    Cancer Res; 2003 Dec; 63(23):8408-13. PubMed ID: 14679003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.